Curtis L. Cetrulo
Fondateur chez Auxocell Laboratories, Inc.
Relations actives
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Alain Klapholz | M | 67 |
OptMed, Inc.
OptMed, Inc. Medical SpecialtiesHealth Technology OptMed, Inc. is a clinical-stage medical device company, which engages in the development and commercialization of surgical adhesives for the treatment of patients with external and internal wounds. The firm offers products under the brands of BondEase Topical Skin Adhesive and TearRepair Liquid Skin Protectant. Its proprietary technology platform is based on a chemistry called methylidene malonate (MM212), a biocompatible polymer originally designed for drug delivery which has been tested for biocompatibility and adhesive properties in topical and internal applications. The company was founded by Alain Klapholz in 2007 and is headquartered in New York, NY. | 17 ans |
Steven B. Sands | M | 65 |
OptMed, Inc.
OptMed, Inc. Medical SpecialtiesHealth Technology OptMed, Inc. is a clinical-stage medical device company, which engages in the development and commercialization of surgical adhesives for the treatment of patients with external and internal wounds. The firm offers products under the brands of BondEase Topical Skin Adhesive and TearRepair Liquid Skin Protectant. Its proprietary technology platform is based on a chemistry called methylidene malonate (MM212), a biocompatible polymer originally designed for drug delivery which has been tested for biocompatibility and adhesive properties in topical and internal applications. The company was founded by Alain Klapholz in 2007 and is headquartered in New York, NY. | 13 ans |
Martin S. Sands | M | 63 |
OptMed, Inc.
OptMed, Inc. Medical SpecialtiesHealth Technology OptMed, Inc. is a clinical-stage medical device company, which engages in the development and commercialization of surgical adhesives for the treatment of patients with external and internal wounds. The firm offers products under the brands of BondEase Topical Skin Adhesive and TearRepair Liquid Skin Protectant. Its proprietary technology platform is based on a chemistry called methylidene malonate (MM212), a biocompatible polymer originally designed for drug delivery which has been tested for biocompatibility and adhesive properties in topical and internal applications. The company was founded by Alain Klapholz in 2007 and is headquartered in New York, NY. | 13 ans |
Rouzbeh Taghizadeh | M | - |
Auxocell Laboratories, Inc.
Auxocell Laboratories, Inc. Medical SpecialtiesHealth Technology Part of BioStem Technologies, Inc., Auxocell Laboratories, Inc. is a company that manufactures solid tissue processing equipment. The company is based in Cambridge, MA. The company was founded by Kyle J. Cetrulo, Curtis L. Cetrulo, Barrett W. Bready, Rouzbeh R. Taghizadeh. Kyle J. Cetrulo has been the CEO since incorporation. Auxocell Laboratories was acquired by BioStem Technologies, Inc. | 16 ans |
Kyle Cetrulo | M | - |
Auxocell Laboratories, Inc.
Auxocell Laboratories, Inc. Medical SpecialtiesHealth Technology Part of BioStem Technologies, Inc., Auxocell Laboratories, Inc. is a company that manufactures solid tissue processing equipment. The company is based in Cambridge, MA. The company was founded by Kyle J. Cetrulo, Curtis L. Cetrulo, Barrett W. Bready, Rouzbeh R. Taghizadeh. Kyle J. Cetrulo has been the CEO since incorporation. Auxocell Laboratories was acquired by BioStem Technologies, Inc. | 16 ans |
James Chao | M | 62 |
OptMed, Inc.
OptMed, Inc. Medical SpecialtiesHealth Technology OptMed, Inc. is a clinical-stage medical device company, which engages in the development and commercialization of surgical adhesives for the treatment of patients with external and internal wounds. The firm offers products under the brands of BondEase Topical Skin Adhesive and TearRepair Liquid Skin Protectant. Its proprietary technology platform is based on a chemistry called methylidene malonate (MM212), a biocompatible polymer originally designed for drug delivery which has been tested for biocompatibility and adhesive properties in topical and internal applications. The company was founded by Alain Klapholz in 2007 and is headquartered in New York, NY. | 2 ans |
Ervin Braun | M | 69 |
OptMed, Inc.
OptMed, Inc. Medical SpecialtiesHealth Technology OptMed, Inc. is a clinical-stage medical device company, which engages in the development and commercialization of surgical adhesives for the treatment of patients with external and internal wounds. The firm offers products under the brands of BondEase Topical Skin Adhesive and TearRepair Liquid Skin Protectant. Its proprietary technology platform is based on a chemistry called methylidene malonate (MM212), a biocompatible polymer originally designed for drug delivery which has been tested for biocompatibility and adhesive properties in topical and internal applications. The company was founded by Alain Klapholz in 2007 and is headquartered in New York, NY. | 12 ans |
Kenneth Burhop | M | 71 |
OptMed, Inc.
OptMed, Inc. Medical SpecialtiesHealth Technology OptMed, Inc. is a clinical-stage medical device company, which engages in the development and commercialization of surgical adhesives for the treatment of patients with external and internal wounds. The firm offers products under the brands of BondEase Topical Skin Adhesive and TearRepair Liquid Skin Protectant. Its proprietary technology platform is based on a chemistry called methylidene malonate (MM212), a biocompatible polymer originally designed for drug delivery which has been tested for biocompatibility and adhesive properties in topical and internal applications. The company was founded by Alain Klapholz in 2007 and is headquartered in New York, NY. | 2 ans |
Merit Cudkowicz | M | 61 |
Harvard Medical School
| - |
David Scadden | M | 71 |
Harvard Medical School
| - |
Barrett W. Bready | M | - |
Auxocell Laboratories, Inc.
Auxocell Laboratories, Inc. Medical SpecialtiesHealth Technology Part of BioStem Technologies, Inc., Auxocell Laboratories, Inc. is a company that manufactures solid tissue processing equipment. The company is based in Cambridge, MA. The company was founded by Kyle J. Cetrulo, Curtis L. Cetrulo, Barrett W. Bready, Rouzbeh R. Taghizadeh. Kyle J. Cetrulo has been the CEO since incorporation. Auxocell Laboratories was acquired by BioStem Technologies, Inc. | 16 ans |
de la Fuente Veronica | M | - |
OptMed, Inc.
OptMed, Inc. Medical SpecialtiesHealth Technology OptMed, Inc. is a clinical-stage medical device company, which engages in the development and commercialization of surgical adhesives for the treatment of patients with external and internal wounds. The firm offers products under the brands of BondEase Topical Skin Adhesive and TearRepair Liquid Skin Protectant. Its proprietary technology platform is based on a chemistry called methylidene malonate (MM212), a biocompatible polymer originally designed for drug delivery which has been tested for biocompatibility and adhesive properties in topical and internal applications. The company was founded by Alain Klapholz in 2007 and is headquartered in New York, NY. | - |
Neil L. Chayet | M | 85 |
Harvard Medical School
| - |
Claus Cursiefen | M | - |
Harvard Medical School
| - |
William R. Sellers | M | 63 |
Harvard Medical School
| - |
Ole Isacson | M | 64 |
Harvard Medical School
| 22 ans |
Deepak Bhatt | M | 56 |
Harvard Medical School
| - |
Alexander G. Marneros | M | - |
Harvard Medical School
| - |
Saurabh Saha | M | 47 |
Harvard Medical School
| - |
Atul Gawande | M | 58 |
Harvard Medical School
| - |
Vijay Kumar Kuchroo | M | 69 |
Harvard Medical School
| - |
Bruce E. Johnson | M | - |
Harvard Medical School
| - |
Laurence Rahme | M | - |
Harvard Medical School
| - |
Michael C. Gibson | M | - |
Harvard Medical School
| 37 ans |
Peter Sorger | M | - |
Harvard Medical School
| - |
Utkan Demirci | M | - |
Harvard Medical School
| - |
Michael Sherling | M | - |
Harvard Medical School
| - |
Marlene Freeman | F | - |
Harvard Medical School
| - |
David Weiner | M | - |
Harvard Medical School
| - |
Jeffrey Flier | M | 76 |
Harvard Medical School
| 17 ans |
Xun Zhang | M | 62 |
Harvard Medical School
| 21 ans |
William D. Carlson | M | - |
Harvard Medical School
| - |
Howard Weiner | M | 78 |
Harvard Medical School
| - |
Beverly M.K. Biller | M | - |
Harvard Medical School
| - |
Barry S. Fogel | M | - |
Harvard Medical School
| 25 ans |
Will Curry | M | - |
Harvard Medical School
| - |
Brenden Boot | M | - |
Harvard Medical School
| - |
David H. Sachs | M | 77 |
Harvard Medical School
| 33 ans |
Joseph Loscalzo | M | 72 |
Harvard Medical School
| - |
Alan Garber | M | 68 |
Harvard Medical School
| - |
Matt Tyson-Durno | M | - |
Harvard Medical School
| - |
Shaké Sulikyan | F | - |
Harvard Medical School
| - |
Missy Carter | F | - |
Harvard Medical School
| - |
Troyen Brennan | M | 69 |
Harvard Medical School
| - |
Rakesh Kumar Jain | M | 74 |
Harvard Medical School
| 33 ans |
H. Franklin Bunn | M | - |
Harvard Medical School
| - |
Cigall Kadoch | M | 39 |
Harvard Medical School
| - |
Peter Libby | M | 77 |
Harvard Medical School
| 28 ans |
Harold J Burstein | M | - |
Harvard Medical School
| - |
Monica Bertagnolli | M | 65 |
Harvard Medical School
| - |
Roy Freeman | M | 72 |
Harvard Medical School
| - |
Paula D. Polito | F | 64 |
Harvard Medical School
| - |
Michael J. McKenna | M | 67 |
Harvard Medical School
| 28 ans |
Isaac Kohane | M | 64 |
Harvard Medical School
| 16 ans |
Jonathan G. Seidman | M | - |
Harvard Medical School
| 43 ans |
Timothy Gregg Ferris | M | 61 |
Harvard Medical School
| - |
Jerome Groopman | M | 72 |
Harvard Medical School
| 32 ans |
Donald William Kufe | M | 79 |
Harvard Medical School
| - |
Ralph Weissleder | M | - |
Harvard Medical School
| - |
Richard Mulligan | M | 69 |
Harvard Medical School
| 28 ans |
Henry J. Aaron | M | - |
Harvard Medical School
| - |
Gregory Verdine | M | 64 |
Harvard Medical School
| 35 ans |
David R. Elmaleh | M | 76 |
Harvard Medical School
| - |
Peter Slavin | M | 66 |
Harvard Medical School
| - |
James J. Mongan | M | 82 |
Harvard Medical School
| 28 ans |
Robert Margolis | M | 77 |
Harvard Medical School
| - |
Lan Bo Chen | M | 80 |
Harvard Medical School
| 27 ans |
Thomas F. Deuel | M | 89 |
Harvard Medical School
| 26 ans |
Choong-Chin Liew | M | - |
Harvard Medical School
| - |
William Kaelin | M | 66 |
Harvard Medical School
| 22 ans |
Marcus Smith | M | 58 |
Harvard Medical School
| - |
N. Coles | M | 63 |
Harvard Medical School
| - |
John Halamka | M | 61 |
Harvard Medical School
| 28 ans |
Bill Helman | M | 65 |
Harvard Medical School
| - |
Alfred Lewis Goldberg | M | 81 |
Harvard Medical School
| 55 ans |
Laurence Paul | M | 59 |
Harvard Medical School
| - |
William F. Crowley | M | - |
Harvard Medical School
| - |
William Gerald Austen | M | 94 |
Harvard Medical School
| 50 ans |
Kasper Lage | M | - |
Harvard Medical School
| - |
Michael B. Brenner | M | - |
Harvard Medical School
| - |
John Halpern | M | - |
Harvard Medical School
| - |
Peter J. Zimetbaum | M | 60 |
Harvard Medical School
| 18 ans |
Sally McNagny | M | - |
Harvard Medical School
| - |
Elsie Tavaras | M | - |
Harvard Medical School
| - |
G. Gilbert | M | 82 |
Harvard Medical School
| - |
Roderick K. King | M | - |
Harvard Medical School
| - |
Alfred Sandrock | M | 67 |
Harvard Medical School
| - |
Joshua Boger | M | 73 |
Harvard Medical School
| - |
Scott A. Shikora | M | - |
Harvard Medical School
| - |
Lynne Zydowsky | M | 65 |
Harvard Medical School
| - |
Steven E. Shoelson | M | - |
Harvard Medical School
| - |
Renu Gupta | M | 68 |
Harvard Medical School
| - |
James Bradner | M | 52 |
Harvard Medical School
| - |
Mason W. Freeman | M | 73 |
Harvard Medical School
| - |
H. Thomas Aretz | M | - |
Harvard Medical School
| - |
Peter T. Lansbury | M | - |
Harvard Medical School
| - |
Kenneth Anderson | M | 72 |
Harvard Medical School
| 22 ans |
Jean-Pierre Kinet | M | 70 |
Harvard Medical School
| 29 ans |
Leonard I. Zon | M | - |
Harvard Medical School
| - |
Miles Shore | M | - |
Harvard Medical School
| - |
Graphique Relationnel
Relation dans plusieurs entreprises
Statistiques
Pays | Relations | % du total |
---|---|---|
Etats-Unis | 100 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Curtis L. Cetrulo
- Réseau Personnel